DH Enchantment, Inc. (ENMI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 3, 2025, 4:00 PM EST
DH Enchantment Revenue
DH Enchantment had revenue of $387.55K in the quarter ending December 31, 2024, a decrease of -34.12%. This brings the company's revenue in the last twelve months to $-42.87K, down -103.10% year-over-year. In the fiscal year ending March 31, 2024, DH Enchantment had annual revenue of $686.00, down -95.46%.
Revenue (ttm)
-42.87K
Revenue Growth
-103.10%
P/S Ratio
-8.94
Revenue / Employee
-42.87K
Employees
1
Market Cap
383.13K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 686.00 | -14.41K | -95.46% |
| Mar 31, 2023 | 15.10K | -533.47K | -97.25% |
| Mar 31, 2022 | 548.57K | 337.02K | 159.31% |
| Mar 31, 2021 | 211.55K | 169.31K | 400.81% |
| Mar 31, 2010 | 42.24K | 35.23K | 502.41% |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 221.55M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 2.61M |